Feed / TVTX

Travere Therapeutics, Inc.

TVTX

Healthcare · 65.70 +2.0% today

Participation confirmed · construction unavailableMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

Travere Therapeutics, Inc.'s move is being confirmed by its market group.

The latest filing evidence is available. 14 of 18 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.

What changed
  • Revenue increased 48.2% versus the comparable filing period.
  • Net margin fell 9.4 percentage points.
Company+2.0% todayVolume comparison unavailable
Market group14 of 18 activeBiotech Rare Diseases · active
Disclosed network0 of 4 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 12 of 18 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as ROIV begins moving with the group.

Invalidation: The live read weakens if participation falls to 6 of 18 members or fewer.

Watch this read

Who this business touches

The relationships behind TVTX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

LGNDLigand Pharmaceuticals IncorporatedpartnerMay 4, 2026

Royalties and Contingent Cash Payments Ligand License Agreement In 2012, we entered into an agreement with Ligand Pharmaceuticals, Inc.

MIRMMirum Pharmaceuticals, Inc.partnerFeb 19, 2026

Sale of Bile Acid Product Portfolio In July 2023, we entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Mirum Pharmaceuticals, Inc.

Depended on by

VERAVera Therapeutics, Inc.competitorMay 7, 2026

Among emerging therapies, we consider our most direct competitors with respect to atacicept in IgAN to be approved products: the reformulated steroid (TARPEYO ® ) from Asahi Kasei Corp., the anti-APRIL monoclonal antibody (VOYXACT ® ) from Otsuka Pharmaceutic…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

TVTX is currently a Participant in the organic co-movement group Biotech Rare Diseases. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.